Family · Pharmaceutical analytical standards
Umeclidinium
A long-acting antimuscarinic inhaled for the maintenance treatment of COPD: approved in the United States in 2013 in a single inhaler with vilanterol, and on its own in 2014. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It is a quinuclidine derivative with a positively charged nitrogen, as the ending -ium suggests: the part of the dose swallowed during inhalation is practically not absorbed from the gut.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
